Supporting this evidence, we have identified target miRNAs in two different models of skeletal muscle hypertrophy (Mstn-null and Magic-F1 mice), where cardiac hypertrophy has a mild phenotype. The gene discussed is MSTN; the disease is Skeletal muscle hypertrophy.